{
    "organizations": [],
    "uuid": "3fb1fb06cdb4e698b46fca5e6929a37cbfcdd97e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-nektar-therapeutics-says-as-of-dec/brief-nektar-therapeutics-says-as-of-dec-31-2017-had-cash-and-investments-of-353-2-mln-idUSFWN1P40U4",
    "ord_in_thread": 0,
    "title": "BRIEF-Nektar Therapeutics Says As Of Dec 31, 2017, Had Cash And Investments Of $353.2 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 9, 2018 / 6:00 PM / Updated 11 minutes ago BRIEF-Nektar Therapeutics Says As Of Dec 31, 2017, Had Cash And Investments Of $353.2 Mln Reuters Staff 1 Min Read \nJan 9 (Reuters) - Nektar Therapeutics: \n* NEKTAR THERAPEUTICS SAYS BASED ON PRELIMINARY ESTIMATES, AS OF DEC 31, 2017, COMPANY HAD CASH AND INVESTMENTS OF $353.2 MILLION - SEC FILING Source text: [ bit.ly/2AJ8qCb ] Further company coverage:",
    "published": "2018-01-09T19:58:00.000+02:00",
    "crawled": "2018-01-09T20:20:32.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "say",
        "dec",
        "cash",
        "investment",
        "mln",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "nektar",
        "therapeutic",
        "nektar",
        "therapeutic",
        "say",
        "based",
        "preliminary",
        "estimate",
        "dec",
        "company",
        "cash",
        "investment",
        "million",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}